DI
MRVI icon

Disciplined Investments’s Maravai LifeSciences MRVI Stock Holding History

Disciplined Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed -$37 – 1004
2023
Q2 		$37 Hold
3
– – ﹤0.01% 1674
2023
Q1 		$42 Buy
3
+1
+50% +$14 ﹤0.01% 1643
2022
Q4 		$29 Buy
2
+1
+100% +$16 ﹤0.01% 1611
2022
Q3 		$0 Buy
+1
New +$25 ﹤0.01% 1460

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Disciplined Investments's MRVI Position: Q3 2023 in Review

Disciplined Investments sold out of Maravai LifeSciences (MRVI) in Q3 2023, closing a stake of 3 shares — an estimated $37 sold.

Disciplined Investments first reported a position in MRVI in Q3 2022 and held it in 4 quarters. The position peaked at $42 in Q1 2023. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

  • Disciplined Investments reported no remaining Maravai LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 3 Maravai LifeSciences shares in Q3 2023, an estimated $37.
  • Disciplined Investments first reported a position in Maravai LifeSciences in Q3 2022 and held it in 4 quarters.
  • Disciplined Investments's Maravai LifeSciences position peaked at $42 in Q1 2023.
  • 204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.